scholarly journals Higher‐risk myelodysplastic syndrome in an elderly patient: Long‐term partial remission with low‐dose prednisone, G‐CSF, and epoetin alfa

2021 ◽  
Vol 9 (9) ◽  
Author(s):  
Anwarul Islam
Keyword(s):  
Elderly Patient ◽  
Myelodysplastic Syndrome ◽  
Partial Remission ◽  
Low Dose ◽  
Epoetin Alfa ◽  
Dose Prednisone

scholarly journals Myelodysplastic Syndrome with Excess of Blasts - Long Term Partial Remission with Low Dose Prednisone, G-CSF and Epoetin Alfa

2021 ◽  
Author(s):  
Anwarul Islam
Keyword(s):  
Elderly Patient ◽  
Myelodysplastic Syndrome ◽  
Low Dose ◽  
Granulocyte Colony Stimulating Factor ◽  
Epoetin Alfa ◽  
Colony Stimulating Factor ◽  
Term Survival ◽  
Stimulating Factor ◽  
Dose Prednisone

We have used low-dose prednisone, in conjunction with granulocyte, colony-stimulating factor (G-CSF) and erythropoietin, to treat an elderly patient with myelodysplastic syndrome (MDS) with an excess of blasts. Our findings indicate that such treatment is safe and may be effective in the long term survival of patients with high-risk MDS.

scholarly journals Ocular myasthenia gravis – How effective is low dose prednisone long term?

2021 ◽  
Vol 420 ◽  
pp. 117274
Author(s):  
Rashmi Verma ◽  
Gil I. Wolfe ◽  
Mark J. Kupersmith
Keyword(s):  
Myasthenia Gravis ◽  
Low Dose ◽  
Ocular Myasthenia ◽  
Ocular Myasthenia Gravis ◽  
Dose Prednisone
Sign in / Sign up

Export Citation Format

Share Document